tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market

ARS Pharmaceuticals (SPRY) Cash flow

Compare
564 Followers

ARS Pharmaceuticals Cash Flow

SPRY's free cash flow for Q4 2025 was $-43.48M. For the 2025 fiscal year, SPRY's free cash flow was decreased by $-184.19M and operating cash flow was $-43.48M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Mar 22
Operating Cash Flow
$ -170.87M$ 13.55M$ -59.27M$ -40.08M$ -17.56M
Investing Cash Flow
$ 56.77M$ -106.10M$ -87.18M$ -199.00K$ -55.00K
Financing Cash Flow
$ 104.60M$ 72.40M$ 6.90M$ 190.73M$ 53.16M
End Cash Position
$ 41.32M$ 50.82M$ 70.97M$ 210.52M$ 60.06M
Free Cash Flow
$ -171.21M$ 12.98M$ -59.44M$ -40.28M$ -17.62M
Currency in USD

ARS Pharmaceuticals Cash Flow